JUN and colorectal carcinoma: However, a study revealed that the deletion of IL‐17RA in CRC is linked to the degradation of A20, which is a negative regulator of the NF‐κB, WNT, and JNK‐c‐Jun signaling pathways, and associated with poor clinical outcome.18